Compare BON & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BON | EDSA |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6M | 12.8M |
| IPO Year | 2021 | N/A |
| Metric | BON | EDSA |
|---|---|---|
| Price | $1.70 | $1.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 41.0K | ★ 49.7K |
| Earning Date | 01-28-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.46 | N/A |
| Revenue | ★ $21,610,848.00 | N/A |
| Revenue This Year | $223.38 | N/A |
| Revenue Next Year | $18.82 | N/A |
| P/E Ratio | $0.66 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.14 | $1.28 |
| 52 Week High | $73.75 | $4.49 |
| Indicator | BON | EDSA |
|---|---|---|
| Relative Strength Index (RSI) | 48.59 | 47.63 |
| Support Level | $1.45 | $1.43 |
| Resistance Level | $1.72 | $1.55 |
| Average True Range (ATR) | 0.11 | 0.10 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 68.56 | 79.41 |
Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.